MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
Ohta
K
K
Clinical Research Center, Utano National Hospital, Kyoto, Japan. mohta@kobepharma-u.ac.jp
Shigemoto
K
K
Kubo
S
S
Maruyama
N
N
Abe
Y
Y
Ueda
N
N
Ohta
M
M
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000918:Antibody Specificity; D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000601:surgery; D009422:Nervous System Diseases / Q000097:blood / Q000276:immunology; D015531:Radioimmunoprecipitation Assay; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D013934:Thymectomy; D013945:Thymoma / Q000097:blood / Q000150:complications / Q000276:immunology / Q000601:surgery; D013953:Thymus Neoplasms / Q000097:blood / Q000150:complications / Q000276:immunology / Q000601:surgery
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D001324:Autoantigens; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D011993:Recombinant Fusion Proteins; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases